<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04700215</url>
  </required_header>
  <id_info>
    <org_study_id>No.01-2020/ED/CPEIC/MULTAN</org_study_id>
    <nct_id>NCT04700215</nct_id>
  </id_info>
  <brief_title>Comparison of BiPAP and ٰIS in Reducing Post CABG Pulmonary Complications</brief_title>
  <official_title>Comparison of Effectiveness of Bilevel Positive Airway Pressure and Incentive Spirometry in Reducing Post CABG Surgery Pulmonary Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chaudhry Pervaiz Elahi Institute of Cardiology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chaudhry Pervaiz Elahi Institute of Cardiology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of Bi-level Positive Airway Pressure (BiPAP) and Incentive Spirometry&#xD;
      (IS) in post CABG patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As postoperative pulmonary complications are major concern in cardiac surgery patients and&#xD;
      our local data is deficient for making better management guidelines. My study aims to provide&#xD;
      a base for future research on this dimension and to decide better management plan for post&#xD;
      cardiac surgical pulmonary complications. The hypothesis is Post extubation BiPAP is more&#xD;
      effective than Incentive Spirometry (IS) in reducing postoperative pulmonary complications in&#xD;
      cardiac surgical patients and the purpose of the study is to evaluate the effect of Bi-level&#xD;
      Positive Airway Pressure (BiPAP) and Incentive Spirometry (IS) in cardiac surgical patients.&#xD;
&#xD;
      This Randomized Controlled Trial (RCT) study will be conducted at Chaudhary pervaiz elahi&#xD;
      institute of cardiology ICU multan.&#xD;
&#xD;
      A sample size of 350 patients will be taken and effect of BiPAP and Incentive spirometry will&#xD;
      be studied in reducing pulmonary complications post CABG surgery. Data will be analyzed&#xD;
      through SPSS. For quantitative variables, mean and standard deviation will be calculated and&#xD;
      for qualitative variables, frequency and percentage will be calculated. Chi square test will&#xD;
      be used to estimate association between qualitative variables. A p value &lt; 0.05 will be&#xD;
      significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post CABG pulmonary complications</measure>
    <time_frame>06 months</time_frame>
    <description>To see the effect of BiPAP and IS in reducing post CABG pulmonary complications</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Pulmonary Complications</condition>
  <arm_group>
    <arm_group_label>Group 01 Effectiveness of BiPAP in reducing post CABG pulmonary complications</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilevel positive airway pressure device after every 6 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 02 Effectiveness of IS in reducing post CABG pulmonary complications</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Incentive spirometry for 15 minutes after every 4 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiPAP</intervention_name>
    <description>To give bilevel positive airway pressure to the lungs</description>
    <arm_group_label>Group 01 Effectiveness of BiPAP in reducing post CABG pulmonary complications</arm_group_label>
    <other_name>Bilevel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Incentive spirometry</intervention_name>
    <description>IS for 15 minutes after every 4 hours</description>
    <arm_group_label>Group 02 Effectiveness of IS in reducing post CABG pulmonary complications</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  CABG patients&#xD;
&#xD;
          -  Patient willing to study&#xD;
&#xD;
          -  Patients planned for on-pump cardiac surgical procedures&#xD;
&#xD;
          -  Both genders (Male &amp; Female)&#xD;
&#xD;
          -  Age 20-60 years&#xD;
&#xD;
          -  Ejection fraction 40-60%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with valvular lesions&#xD;
&#xD;
          -  Off-pump cardiac surgery&#xD;
&#xD;
          -  Refusal to give consent for BiPAP&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  Previous cardiac surgery&#xD;
&#xD;
          -  Obesity BMI&gt;30&#xD;
&#xD;
          -  ASA status V&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammad Imran Khan, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chaudhry Pervaiz Elahi Institute of Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Muhammad Imran Khan</last_name>
    <phone>+923326366121</phone>
    <email>imrkhan803@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Muhamma Imran I khan, MBBS</last_name>
    <phone>+923326366121</phone>
    <email>imrkhan803@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CPEIC</name>
      <address>
        <city>Multān</city>
        <state>Punjab</state>
        <zip>66000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muhammad Imran Khan, MBBS</last_name>
      <phone>+923326366121</phone>
      <email>imrkhan803@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>January 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chaudhry Pervaiz Elahi Institute of Cardiology</investigator_affiliation>
    <investigator_full_name>Muhammad Imran Khan</investigator_full_name>
    <investigator_title>Doctor Muhammad Imran Khan</investigator_title>
  </responsible_party>
  <keyword>CABG</keyword>
  <keyword>BiPAP</keyword>
  <keyword>IS</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

